Dimerix Ltd (DXB)

Currency in AUD
0.495
+0.005(+1.02%)
Delayed Data·
DXB Scorecard
Full Analysis
Liquid assets exceed short term obligations
DXB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.4900.505
52 wk Range
0.3000.785
Key Statistics
Bid/Ask
0.49 / 0.50
Prev. Close
0.49
Open
0.5
Day's Range
0.49-0.505
52 wk Range
0.3-0.785
Volume
293.15K
Average Volume (3m)
2.14M
1-Year Change
30.67%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DXB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Operates with a moderate level of debt

Dimerix Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Dimerix Ltd Company Profile

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. The company develops DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 which is in phase 2 clinical trial for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for chronic obstructive pulmonary disease, as well as develops proprietary receptor- HIT assay technology. Dimerix Limited is headquartered in Fitzroy, Australia.

Compare DXB to Peers and Sector

Metrics to compare
DXB
Peers
Sector
Relationship
P/E Ratio
−12.0x−4.9x−0.5x
PEG Ratio
0.24−0.050.00
Price/Book
38.9x3.0x2.6x
Price / LTM Sales
378.2x13.6x3.3x
Upside (Analyst Target)
80.6%305.8%42.8%
Fair Value Upside
Unlock10.7%6.5%Unlock

Earnings

Latest Release
Feb 24, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
287.45K / --
EPS Revisions
Last 90 days

DXB Income Statement

FAQ

What Stock Exchange Does Dimerix Trade On?

Dimerix is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Dimerix?

The stock symbol for Dimerix is "DXB."

What Is the Dimerix Market Cap?

As of today, Dimerix market cap is 295.87M.

What Is Dimerix's Earnings Per Share (TTM)?

The Dimerix EPS (TTM) is -0.04.

From a Technical Analysis Perspective, Is DXB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Dimerix Stock Split?

Dimerix has split 10 times.

How Many Employees Does Dimerix Have?

Dimerix has 0 employees.

What is the current trading status of Dimerix (DXB)?

As of 06 Aug 2025, Dimerix (DXB) is trading at a price of 0.50, with a previous close of 0.49. The stock has fluctuated within a day range of 0.49 to 0.51, while its 52-week range spans from 0.30 to 0.79.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.